Invex Therapeutics Ltd. (AU:IXC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Invex Therapeutics Ltd has reported a change in the holdings of director Dr. Megan Baldwin, who disposed of 400,000 unlisted options and now holds 100,000 options exercisable at $0.87 with vesting conditions, via their related party GAJA Holdings. The change, described as a cancellation of unlisted options, took place on April 8, 2024.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.